New York, New York (PRWEB) July 04, 2014
DePuy ASR hip lawsuits (http://www.consumerinjurylawyers.com/DePuy/) filed in the wake 2010 recall of the metal-on-metal hip continue to move forward in the U.S. District Court, Northern District of Ohio, Bernstein Liebhard LLP reports. According to an Order issued by the Court on June 30, 2014, the litigation’s next Status Conference has been scheduled for July 18, 2014 at 9:30 a.m. During the conference, the Court will address a progress report from the litigation’s leadership, as well as oral arguments on certain pending motions. (In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation – MDL 2197)
“Our Firm is representing numerous plaintiffs in the DePuy ASR recall litigation. We are pleased to see the proceeding moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free legal evaluations to individuals who allegedly experienced metallosis, chronic pain, disability, premature hip implant failure, and other serious complications allegedly related to devices included in the DePuy ASR recall.
DePuy ASR Litigation
According to court documents, more than 12,000 DePuy ASR lawsuits have been filed in courts throughout the U.S. since the metal-on-metal hip implants were pulled from the market in August 2010. The majority of these cases are pending in the proceeding underway in the Northern District of Ohio. Plaintiffs in these claims allege that the all-metal design of the ASR can cause it to shed dangerous amounts of toxic metal debris into recipients’ tissue and blood stream. This has the potential to cause a number of serious complications, including metallosis, chronic pain, and early device failure.
Court records indicate that a DePuy ASR settlement was proposed in the Northern District of Ohio last November that would resolve some 8,000 of the 12,000 complaints filed since the recall. In May, Johnson & Johnson, the parent company of DePuy Orthopaedics, waived its “walk away rights” after a majority of eligible claimants agreed to accept the terms of the settlement, paving the way for the settlement to be finalized.
According to the DePuy ASR settlement agreement, plaintiffs qualified to participate in the program include those who underwent revision surgery to replace their ASR hip due to a recall-related reason prior to August 31, 2013. Eligible claimants would be entitled to a base award of $250,000. That award could be reduced, however, depending on certain other factors, including their prior medical history. Other circumstances could entitle plaintiffs to a supplemental award if they, for example, required multiple revision surgeries, or if they experience "certain extraordinary injuries" in the future. Plaintiffs who do not wish to participate, or those who are not eligible, will still be permitted to pursue individual claims against the companies.
Individuals who were allegedly harmed by a DePuy ASR hip implant may be entitled to compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a DePuy ASR lawsuit, please visit Bernstein Liebhard LLP’s website. For a free, no obligation case review, please call the Firm directly at 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com